Abstract
Over the last decade, several new antihyperglycemic medications have been introduced including those associated with a lower hypoglycemia risk. We aimed to investigate how these medications are being prescribed to older adults in our region. We conducted population-based cross-sectional analyses of older adults (mean age 75 years) with treated diabetes in Ontario, Canada from 2002 until 2013, to examine the percentage prescribed insulin, sulphonylureas, alpha-glucosidase inhibitors, metformin, thiazolidinediones, meglitinides, and dipeptidyl peptidase-4 inhibitors. Over the study period, we also examined their hospital encounters for hypoglycemia (emergency room or inpatient encounter). The mean age of treated patients increased slightly over the study quarters and the proportion that were women declined. With the exception of chronic kidney disease, cancer, dementia, and neuropathy, the percentage with a comorbidity appeared to decline. The percentage of treated patients prescribed metformin, gliclazide and dipeptidyl peptidase-4 inhibitors increased as did combination therapy. Glyburide and thiazolidinedione prescriptions declined, and insulin use remained stable. In those with newly treated diabetes, the majority were prescr...Continue Reading
References
Jun 1, 1997·Journal of Clinical Epidemiology·T van StaaJ Monette
Mar 5, 2002·Diabetes Care·Janet E HuxAdina Bica
Jun 6, 2002·Diabetes, Obesity & Metabolism·A J GarberUNKNOWN Glyburide/Metformin Initial Therapy Study Group
Apr 28, 2005·Diabetes Care·Gillian L BoothBenjamin T B Chan
Oct 11, 2005·Lancet·John A DormandyUNKNOWN PROactive Investigators
Dec 22, 2005·Diabetes, Obesity & Metabolism·J RosenstockUNKNOWN RESULT Study Group
Oct 10, 2006·Diabetes, Obesity & Metabolism·J RosenstockA Garber
Mar 30, 2007·Diabetes Care·Wolfgang RathmannGuido Giani
Sep 13, 2007·JAMA : the Journal of the American Medical Association·A Michael LincoffSteven E Nissen
Dec 13, 2007·JAMA : the Journal of the American Medical Association·Lorraine L LipscombeDavid A Alter
Jan 29, 2008·Diabetes Care·Steven E KahnUNKNOWN Diabetes Outcome Progression Trial (ADOPT) Study Group
Mar 4, 2008·Journal of Clinical Epidemiology·Erik von ElmUNKNOWN STROBE Initiative
Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Jun 9, 2009·Lancet·Philip D HomeUNKNOWN RECORD Study Team
Jul 22, 2009·Pharmacoepidemiology and Drug Safety·Kristian B FilionJames M Brophy
Jan 28, 2010·Diabetes Care·Andrew CohenG Caleb Alexander
Jul 27, 2010·Archives of Internal Medicine·Steven E Nissen, Kathy Wolski
Feb 18, 2011·Current Medical Research and Opinion·Jean DoucetJulio Rosenstock
May 31, 2011·Diabetes Research and Clinical Practice·Marta BavieraMaria Carla Roncaglioni
Feb 22, 2012·The American Journal of Medicine·Nihar R DesaiNiteesh K Choudhry
Mar 28, 2013·Diabetes, Obesity & Metabolism·J RosenstockP Fleck
Apr 17, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·P D FosterT Gomes
Sep 10, 2013·Irish Journal of Medical Science·N L ZaharanK Bennett
Dec 11, 2013·JAMA Internal Medicine·Elbert S HuangAndrew J Karter
Mar 14, 2014·Diabetes Care·Christian HamppDiane K Wysowski
May 20, 2014·JAMA Internal Medicine·Kasia J LipskaHarlan M Krumholz
Jul 26, 2014·BMJ Open·David N JuurlinkUNKNOWN Canadian Drug Safety and Effectiveness Research Network (CDSERN)
Apr 1, 2013·Journal of American College Health : J of ACH·Craig W Trumbo, Raquel Harper
Oct 16, 2015·Hypertension·Elsayed Z SolimanHaiying Chen
Citations
Apr 15, 2016·Current Diabetes Reports·Vishal Ahuja, Chia-Hung Chou
Sep 21, 2016·PloS One·Mathieu BoulinCara Tannenbaum
Jul 21, 2016·Vascular Pharmacology·Hye Won KimWon Sun Park
Feb 17, 2017·Cardiovascular Diabetology·Aurélien MarySaïd Kamel
Jun 3, 2017·Fundamental & Clinical Pharmacology·Mickael ArnaudFrancesco Salvo
Apr 28, 2017·Diabetes, Obesity & Metabolism·Juri ParkDoo Man Kim
Dec 28, 2017·Internal Medicine·Ritsuko Yamamoto-HondaMitsuhiko Noda
Nov 14, 2017·Circulation. Heart Failure·Rohan KheraJarett D Berry
Oct 30, 2018·Diabetes, Obesity & Metabolism·Timothy M E DavisWendy A Davis
Dec 21, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Abdallah Y NaserLi Wei
Aug 12, 2017·JBI Database of Systematic Reviews and Implementation Reports·Jared M CampbellEdoardo Aromataris
Aug 20, 2020·The International Journal of Pharmacy Practice·Thananan Rattanachotphanit, Onanong Waleekhachonloet
Jan 11, 2020·Endocrinology, Diabetes & Metabolism·Kristy IglayKamlesh Khunti
Aug 29, 2016·European Journal of Clinical Pharmacology·J MoonR O Day
Aug 29, 2018·Journal of Alzheimer's Disease : JAD·Jared M CampbellEdoardo Aromataris
May 3, 2018·Diabetologia·Francesco ZaccardiKamlesh Khunti
Oct 13, 2018·Scientific Reports·John-Michael GambleSumit R Majumdar
Mar 21, 2019·World Journal of Diabetes·Wisit KaewputWisit Cheungpasitporn
Aug 21, 2018·International Journal of Endocrinology·Pendar Farahani
Dec 7, 2018·Cardiovascular Toxicology·Mi Seon SeoWon Sun Park
Aug 30, 2019·Pharmacoepidemiology and Drug Safety·Matthew H SecrestKristian B Filion
Aug 24, 2017·Cardiovascular Therapeutics·Hongliang LiWon Sun Park
Oct 24, 2020·JAMA Network Open·Rohan KheraAmbarish Pandey
Nov 27, 2020·Clinical Journal of the American Society of Nephrology : CJASN·Flory T MuandaAmit X Garg
Jun 15, 2020·European Journal of Pharmacology·Hee Seok JungWon Sun Park
Nov 27, 2020·Diabetes Research and Clinical Practice·Domingo Orozco-BeltránConcepción Carratalá-Munuera
Mar 4, 2020·Archives of Gerontology and Geriatrics·Ming-Yueh ChouLiang-Kung Chen